SB 317 Utah Senate · 2026 General Session

Opioid Terminology Amendments

SB 317 updates Utah's legal terminology by replacing "opiate" with "opioid" in definitions across multiple statutes. It specifically changes terms like "opiate antagonist" to "opioid antagonist" and "opiate-related drug overdose event" to "opioid-related drug overdose event," while also updating related references to "opiate" in controlled substances descriptions. The bill coordinates these changes with other opioid-related legislation (H.B. 301, S.B. 87, and S.B. 98) to ensure consistent terminology without altering existing policies or adding new requirements. No funding is appropriated, and the changes only affect how Utah law references opioid-related terms in existing statutes.
Bill status passed 4 of 5 stages cleared
Introduction
Feb 2026
Committee Review
Mar 2026
Senate Passage
Mar 2026
House Passage
Mar 2026
Governor
Introduced Feb 23, 2026 Last action Mar 7, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Substitute #1 · 7 edits
MODERATE
This bill updates Utah state laws to replace the term 'opiate' with 'opioid' or 'opioid-like substance' throughout the code to align with modern medical terminology. It also expands legal protections for healthcare providers and community members who distribute naloxone (opioid antagonists) to prevent overdoses, clarifying that they cannot be sued for civil damages when acting in good faith. Additionally, the bill mandates that pharmacies offering naloxone to patients at risk of overdose must also provide counseling on its use.
Scope change
The bill broadens the scope of legal immunity to include a wider range of individuals (such as family members and friends) who assist in administering naloxone during an overdose event, whereas previous laws primarily focused on healthcare providers and specific outreach organizations.
DEFINITION

Replaced the legal term 'opiate' with 'opioid' or 'opioid-like substance' in over 20 different statutes to ensure consistency with current medical standards.

ELIGIBILITY

Expanded the definition of 'overdose outreach provider' to explicitly include family members, friends, and other individuals in a position to assist someone at risk of an overdose event.

REQUIREMENT

Added a requirement for pharmacies dispensing certain opioids to offer counseling and dispense naloxone to patients receiving high doses or those prescribed benzodiazepines concurrently.

Mandated that syringe exchange programs provide verbal and written instruction on obtaining naloxone to individuals receiving new syringes.

Updated reporting requirements for county jails and the Department of Corrections to include data on in-custody deaths and withdrawal treatment protocols.

ENFORCEMENT

Created a new pilot program to provide grants to organizations (including schools and law enforcement) for purchasing and distributing naloxone to at-risk individuals.

TECHNICAL

Renumbered and updated various Utah Code sections to reflect the terminology changes and new provisions.

Floor votes · Senate Mar 4, 2026

How they voted

260
Passed · 3 other
Total votes 29
Mar 4, 2026
D Democratic6
6 Yea
100% Yea
N Forward1
1 Yea
100% Yea
R Republican22
19 Yea 3
86% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
32
Key actions
4
Committee
4
Mar 4, 2026
Senate · Passed
Senate Vote: pass (26-0-3)
senate
Mar 4, 2026
Introduced
House/ 1st reading (Introduced)
lower
Mar 3, 2026
Upper · Passed
Senate/ comm rpt/ substituted/ Consent Calendar [Senate Health and Human Services Committee]
upper
Mar 2, 2026
Upper · Passed
Senate Comm - Consent Calendar Recommendation [Senate Health and Human Services Committee]
upper
Mar 2, 2026
Upper · Passed
Senate Comm - Favorable Recommendation [Senate Health and Human Services Committee]
upper
Feb 25, 2026
Committee
Senate/ to standing committee [Senate Health and Human Services Committee]
upper
Feb 23, 2026
Introduced
Senate/ 1st reading (Introduced)
upper
1 primary · 1 co-sponsor

Sponsors